Tecan concludes the sale of the Sample Management activities to NEXUS Biosystems
The Tecan Group announced that the sale of REMP AG, a wholly owned subsidiary of Tecan, as well as other related assets, to NEXUS Biosystems has been completed as planned. From September 1, 2010, the Sample Management business segment will no longer be consolidated within the Tecan Group. It will be presented in the 2010 financial statements as a discontinued operation.
Tecan announced that it would sell all the activities of the Sample Management business segment to NEXUS as part of its strategic portfolio alignment. Tecan will now focus its resources on growth projects in its core business and actively expand both its end-customer business and its OEM activities.
Most read news
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
New Standards in Biotechnology
Valneva and BliNK Therapeutics Launch of New Biotech Company - New company has already secured first round of financing
Charles_Platt
Roche Diagnostics Licenses the Technology used for the LightCycler System to BIOTECON
Closing of public offering of Argos Therapeutics
Pakistan_Red_Crescent_Society
Human_Y-chromosome_DNA_haplogroups
